EW Edwards Lifesciences Corporation Common Stock
$92,49
Harga · Agu 19, 2026
Fundamental per Agu 4, 2026
Rentang 52M
$72–$96
84% of range
Peringkat Analis
BUY
40 analysts
Target Harga
$101
+9% upside
P/E (TTM)
57.4
ROE
10.6%
Margin Laba Bersih
17.7%
Tentang Edwards Lifesciences Corporation Common Stock Tinjauan perusahaan dari Wikipedia
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.
Baca selengkapnya
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.
History
Edwards Lifesciences was originally founded by electrical engineer Miles "Lowell" Edwards in 1958, a graduate of Oregon State University. Edwards invented the first medically proven and adopted artificial heart valve. Dr. Albert Starr, a surgeon at the Oregon Health and Sciences University, is credited as the first to successfully implant the Starr-Edwards mitral valve in a patient in 1960. As a result of the successful heart implant, Edwards established manufacturing in Santa Ana, California the same year to continue his research in pulmonary devices.
Edwards' valves are still in operation today. An early patient lived a record 48 years with the implant before requiring a replacement.
Edwards was acquired by Baxter in 1985. It was spun off from Baxter in 2000.
In 2017, Edwards completed the acquisition of Valtech Cardio for $340 million. Also in 2017, Edwards acquired Harpoon Medical of Baltimore, Maryland for $100 million. Harpoon, founded in 2013, developed a minimally invasive heart surgery product for mitral valve repair to treat degenerative mitral regurgitation. At the time of the acquisition, the product was not available on any market.
On April 18, 2019, Edwards completed the acquisition of CAS Medical Systems of Branford, Connecticut for ~$100 million.
Edwards Sapien 3 and Sapien 3 Ultra Transcatheter Heart Valve systems were FDA-approved for the treatment of patients at low risk for death or major complications associated with open-heart surgery on August 16, 2019. These products are used to treat patients with severe aortic stenosis without utilizing open-heart surgery.
In 2020, Edwards co-sponsored the Virtual ISPOR-FDA Summit centered on patient preference information in medical device regulatory decisions.
In December 2021, the FDA approved the SAPIEN 3 transcatheter valve in combination with the Alterra adaptive prestent for the treatment of severe pulmonary regurgitation.
In February 2024, the FDA approved Edwards' EVOQUE tricuspid valve replacement system, the first transcatheter therapy approved in the United States for the treatment of tricuspid regurgitation. In May 2024, Edwards launched the SAPIEN 3 Ultra RESILIA valve in Europe.
In June 2024, the company received FDA approval for a new implant designed to manage heart failure issues, called the Cordella pulmonary artery sensor.
In July 2024, Edwards made agreements with Affluent Medical for an equity stake, IP licensing and an exclusive option to acquire its Kephalios subsidiary. The same month, Edwards announced it would acquire Innovalve Bio Medical for approximately $300 million, and JenaValve Technology and Endotronix for $1.2 billion.
In August 2024, Edwards acquired JC Medical from Genesis MedTech, gaining its J-Valve transcatheter aortic valve replacement system for the treatment of aortic regurgitation.
In 2023, Edwards announced that its critical care business unit would be spun off into a separate entity. In June 2024 Edwards instead agreed to sell the unit to BD for $4.2 billion. The sale closed on September 3, 2024.
In May 2025, the FDA approved the SAPIEN 3 platform, including the SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA valves, for the treatment of severe aortic stenosis in asymptomatic patients, marking the first FDA approval of TAVR therapy for this patient population.
In September 2025, Edwards completed the full acquisition of heart failure monitoring company Vectorious Medical Technologies.
In January 2026, the FDA approved the SAPIEN M3 mitral valve replacement system, the first transcatheter mitral valve replacement therapy using a transseptal approach to receive FDA approval for the treatment of mitral regurgitation.
Business segments
Prior to September 2024, its products were categorized into four areas: surgical valve technologies, transcatheter heart valves, transcatheter mitral and tricuspid therapies, and critical care. In September 2024, Edwards completed the sale of its Critical Care product group to BD. Since September 2024, its products are categorized into four areas: surgical valve technologies, transcatheter heart valves, transcatheter mitral and tricuspid therapies, and implantable heart failure management (IHFM).
Transcatheter Heart Valve
The company's SAPIEN family of transcatheter aortic heart valves is made of bovine pericardial tissue mounted within a balloon-expandable, cobalt-chromium frame and is deployed via catheter. Edwards introduced the transcatheter heart valve replacement procedure to U.S. patients unable to undergo open-heart surgery with FDA approval of the SAPIEN transcatheter valve in 2011. The indication was expanded in November 2012 to include patients at a high risk for death or serious complications associated with open-heart surgery. In 2021, the FDA cleared Edwards’ SAPIEN 3 transcatheter valve with the Alterra adaptive prestent for pulmonic heart valve replacement. In May 2024, Edwards launched the SAPIEN 3 Ultra RESILIA valve in Europe.
Transcatheter Mitral and Tricuspid Therapies
The Transcatheter Mitral and Tricuspid Therapies business segment develops transcatheter heart valve repair and replacement technologies to treat mitral and tricuspid valve diseases. In September 2022, the FDA approved Edwards' PASCAL Precision transcatheter valve repair system for the treatment of degenerative mitral regurgitation.
Surgical
The Surgical business segment involves the use of Edwards' RESILIA tissue technology, developed to help limit valve calcification. Edwards estimates that more than 450,000 patients around the world have either undergone SAVR or TAVR with an Edwards RESILIA valve.
Critical Care
Before its sale, the Critical Care business segment included pulmonary artery catheters, disposable pressure transducers and advanced hemodynamic monitoring systems. The portfolio also included a line of balloon catheter-based vascular products, surgical clips and inserts. In 2023, it was announced that the critical care business unit was to be spun off into its own entity, however in 2024 the critical care department was purchased by BD for $4.2 billion.
Organizational culture
Edwards Lifesciences Foundation
The Edwards Lifesciences Foundation launched in 2014 and supports programs designed to treat underserved people to reduce heart valve disease.
Since the initiative launched in 2014, Edwards and its foundation have contributed more than $100 million in financial and technology donations through "Every Heartbeat Matters" (EHM), reaching over 4 million underserved structural heart patients globally.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
EW Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$92.49
Kapitalisasi Pasar
$61.04B
P/E (TTM)
57.4
EPS (TTM)
$1.83
Pendapatan (TTM)
$6.07B
Imbal Hasil Dividen
—
ROE
10.6%
D/E Utang/Ekuitas
0.1
Rentang 52M
$72 – $96
EW Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$6.07B
2016-12-31
→
2025-12-31
EPS
$1.83
2016-12-31
→
2025-12-31
Arus Kas Bebas
$1.33B
2016-12-31
→
2025-12-31
Margin
17.7%
2016-12-31
→
2025-12-31
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
EW
Median Rekan
P/E (TTM)
57.4
26.3
P/S (TTM)
10.1
4.4
P/B
5.9
5.3
EV / EBITDA
40.4
—
Price / FCF (Harga / FCF)
45.7
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
EW
Median Rekan
Gross Margin (Margin Kotor)
78.0%
63.1%
Operating Margin (Margin Operasi)
20.8%
—
Net Profit Margin (Margin Laba Bersih)
17.7%
15.6%
ROA
8.0%
7.6%
ROE
10.6%
15.0%
ROIC
9.6%
—
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
EW
Median Rekan
Debt / Equity (Utang / Ekuitas)
0.1
—
Current Ratio (Rasio Lancar)
3.7
1.7
Quick Ratio (Rasio Cepat)
2.7
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
EW
Median Rekan
Revenue YoY (Pendapatan YoY)
11.6%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
10.8%
—
Revenue CAGR 5Y (CAGR Pendapatan 5T)
6.7%
—
EPS YoY
-73.7%
—
Net Income YoY (Laba Bersih YoY)
-74.3%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
EW
Median Rekan
EW Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
40 analis
- Beli Kuat 13 32,5%
- Beli 17 42,5%
- Tahan 10 25,0%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
26 analis · 2026-08-19
Median
$101.50
Sekarang
$92.49
Rendah
$84.00
Tinggi
$110.00
Target median
$101.50
+9,7%
Target rata-rata
$100.96
+9,2%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.02%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $0.78 | $0.76 | 0.02% |
| 31 Maret 2026 | $0.78 | $0.75 | 0.03% |
| 31 Des. 2025 | $0.58 | $0.64 | -0.06% |
| 30 Sep. 2025 | $0.67 | $0.61 | 0.06% |
| 30 Juni 2025 | $0.67 | $0.64 | 0.03% |
| 31 Maret 2025 | $0.64 | $0.61 | 0.03% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 17
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.07B | $5.44B | $5.01B | $4.46B | $5.23B | $4.39B | $4.35B | $3.72B | $3.44B | $2.96B | $2.49B | $2.32B | |
| Cost of Revenue | $1.33B | $1.12B | $978M | $724M | $1.25B | $1.08B | $1.11B | $939M | $875M | $797M | $617M | $626M | |
| Gross Profit | $4.73B | $4.32B | $4.03B | $3.74B | $3.98B | $3.31B | $3.23B | $2.78B | $2.56B | $2.17B | $1.88B | $1.70B | |
| R&D Expense | $1.08B | $1.05B | $963M | $844M | $903M | $761M | $753M | $622M | $553M | $442M | $383M | $346M | |
| SG&A Expense | $2.09B | $1.79B | $1.58B | $1.36B | $1.49B | $1.23B | $1.24B | $1.09B | $991M | $905M | $851M | $858M | |
| Operating Income | $1.26B | $1.38B | $1.31B | $1.50B | $1.69B | $898M | $1.15B | $748M | $1.09B | $751M | · | · | |
| Interest Expense | · | · | $18M | $19M | $18M | $16M | $21M | $30M | $23M | $19M | $17M | $17M | |
| Interest Income | $169M | $120M | $67M | $36M | $17M | $23M | $32M | $32M | $20M | $11M | $8M | $6M | |
| Other Non-op | $7M | $69M | $14M | $5M | $13M | $12M | $8M | $4M | $-1M | $-5M | $-4M | $-8M | |
| Pretax Income | $1.27B | $1.55B | $1.37B | $1.52B | $1.70B | $917M | $1.17B | $761M | $1.03B | $738M | $622M | $1.14B | |
| Income Tax | $217M | $152M | $152M | $196M | $199M | $93M | $120M | $39M | $451M | $168M | $128M | $333M | |
| Net Income | $1.07B | $4.17B | $1.40B | $1.52B | $1.50B | · | · | · | · | · | · | · | |
| EPS (Basic) | $1.84 | $6.98 | $2.31 | $2.46 | $2.41 | $1.32 | $1.68 | $1.15 | $2.77 | $2.67 | $2.30 | $3.81 | |
| EPS (Diluted) | $1.83 | $6.97 | $2.30 | $2.44 | $2.38 | $1.30 | $1.64 | $1.13 | $2.70 | $2.61 | $2.25 | $3.74 | |
| Shares (Basic) | 584,800,000 | 597,700,000 | 606,700,000 | 619,000,000 | 623,300,000 | 622,600,000 | 624,800,000 | 627,600,000 | 210,900,000 | 213,000,000 | 215,500,000 | 213,000,000 | |
| Shares (Diluted) | 585,800,000 | 599,300,000 | 609,400,000 | 624,200,000 | 631,200,000 | 631,900,000 | 636,700,000 | 640,900,000 | 215,900,000 | 217,800,000 | 220,300,000 | 217,000,000 | |
| EBITDA | $1.42B | $1.53B | $1.68B | $1.89B | $1.83B | $1.00B | $1.24B | $826M | $82M | $71M | $66M | $69M |
Neraca 29
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.94B | $3.05B | $1.13B | $769M | $863M | $1.18B | $1.18B | $714M | $818M | $930M | $718M | $654M | |
| Short-term Investments | $1.29B | $931M | $500M | $446M | $604M | $219M | $338M | $242M | $519M | $341M | $506M | $785M | |
| Receivables | $660M | $609M | $772M | $643M | $582M | $515M | $544M | $457M | $439M | $366M | $315M | $288M | |
| Inventory | $1.13B | $1.09B | $904M | $876M | $727M | $802M | $641M | $607M | $555M | $397M | $340M | $297M | |
| Prepaid Expense | $135M | $121M | $129M | $110M | $85M | $75M | $59M | $54M | $61M | $46M | $45M | $49M | |
| Other Current Assets | $339M | $348M | $225M | $196M | $237M | $208M | $168M | $132M | $117M | $112M | $66M | $122M | |
| Current Assets | $6.74B | $6.29B | $4.04B | $3.10B | $3.18B | $3.09B | $2.98B | $2.29B | $2.55B | $2.24B | $2.05B | $2.23B | |
| PP&E (Net) | $1.81B | $1.69B | $1.59B | $1.63B | $1.55B | $1.40B | $1.06B | $868M | $680M | $580M | $482M | $443M | |
| PP&E (Gross) | $2.66B | $2.48B | $2.29B | $2.38B | $2.20B | $1.99B | $1.57B | $1.32B | $1.09B | $961M | $854M | $808M | |
| Accum. Depreciation | $850M | $794M | $699M | $750M | $655M | $598M | $512M | $455M | $412M | $381M | $372M | $365M | |
| Goodwill | $1.77B | $1.78B | $1.15B | $1.06B | $1.17B | $1.17B | $1.17B | $1.11B | $1.13B | $626M | $628M | $376M | |
| Intangibles | $1.13B | $1.18B | $399M | $285M | $324M | $331M | $336M | $343M | $468M | $205M | $205M | $23M | |
| Other Non-current Assets | $730M | $722M | $463M | $299M | $111M | $120M | $102M | $34M | $109M | $123M | $132M | $49M | |
| Total Assets | $13.70B | $13.06B | $9.36B | $8.29B | $8.50B | $7.24B | $6.49B | $5.32B | $5.67B | $4.51B | $4.06B | $3.52B | |
| Accounts Payable | $228M | $197M | $187M | $202M | $204M | $196M | $180M | $134M | $117M | $97M | $64M | $58M | |
| Current Liabilities | $1.81B | $1.51B | $1.20B | $1.02B | $1.03B | $894M | $902M | $877M | $1.42B | $532M | $476M | $426M | |
| Capital Leases | $83M | $79M | $65M | $70M | $69M | $73M | $59M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | $37M | · | · | · | · | · | |
| Other Non-current Liabilities | $362M | $373M | $251M | $218M | $267M | $252M | $203M | $150M | $147M | $115M | $285M | $113M | |
| Total Liabilities | $3.36B | $2.99B | $2.64B | $2.49B | $2.67B | $2.66B | · | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | $594M | $1.04B | $822M | · | · | |
| Total Debt | $598M | $598M | $597M | $596M | $596M | $595M | $594M | $594M | $1.04B | $822M | $600M | $598M | |
| Common Stock | $659M | $655M | $650M | $646M | $642M | $636M | $218M | $215M | $212M | $243M | $239M | $129M | |
| Retained Earnings | $14.24B | $13.17B | $8.99B | $7.59B | $6.07B | $4.57B | $3.74B | $2.69B | $1.96B | $3.91B | $3.34B | $2.84B | |
| Treasury Stock | $7.09B | $6.19B | $5.02B | $4.14B | $2.42B | $1.90B | $1.28B | $1.02B | $252M | $2.50B | $1.84B | $1.56B | |
| AOCI | $-238M | $-244M | $-243M | $-255M | $-158M | $-161M | $-156M | $-138M | $-133M | $-198M | $-183M | $-101M | |
| Stockholders' Equity | $10.34B | $10.00B | $6.65B | $5.81B | $5.84B | $4.57B | $4.15B | $3.14B | $2.96B | $2.62B | $2.50B | $2.19B | |
| Liabilities + Equity | $13.70B | $13.06B | $9.36B | $8.29B | $8.50B | $7.24B | $6.49B | $5.32B | $5.67B | $4.51B | $4.06B | $3.52B | |
| Shares Outstanding | 580,700,000 | 654,800,000 | 650,500,000 | 646,300,000 | 642,000,000 | 636,400,000 | 218,100,000 | 207,700,000 | 209,700,000 | 211,600,000 | 215,400,000 | 107,800,000 |
Arus Kas 18
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $157M | $155M | $145M | $140M | $135M | $107M | $89M | $77M | $82M | $71M | $66M | $69M | |
| Stock-based Comp | $158M | $162M | $139M | $127M | $109M | $93M | $81M | $71M | $62M | $57M | $50M | $48M | |
| Deferred Tax | $-66M | $-163M | $-242M | $-262M | $-44M | $-52M | $10M | $-21M | $27M | $-24M | $-16M | $-67M | |
| Amort. of Intangibles | $8M | $6M | $2M | $2M | $8M | $5M | $5M | $2M | $8M | $8M | $7M | $8M | |
| Restructuring | $13M | $33M | · | · | · | · | · | · | · | · | $0 | $0 | |
| Other Non-cash | $273M | $-3.79B | $-529M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $1.60B | $542M | $896M | $1.22B | $1.73B | $1.05B | $1.18B | $927M | $1.00B | $704M | $550M | $1.02B | |
| CapEx | $260M | $252M | $253M | $245M | $326M | $407M | $254M | $239M | $168M | $176M | $103M | $83M | |
| Investing Cash Flow | $-713M | $2.31B | $174M | $252M | $-1.72B | $-531M | $-596M | $77M | $-647M | $-212M | $-316M | · | |
| Debt Issued | · | · | $0 | $0 | $5M | $16M | $19M | $688M | $995M | $254M | $31M | $226M | |
| Net Debt Issued | · | · | $0 | $0 | $5M | $16M | $19M | $688M | $995M | $254M | $31M | $226M | |
| Stock Repurchased | $893M | $1.16B | $880M | $1.73B | $513M | $625M | $263M | $796M | $763M | $662M | $280M | $301M | |
| Net Stock Activity | $-893M | $-1.16B | $-880M | $-1.73B | $-513M | $-625M | $-263M | $-796M | $-763M | $-662M | $-280M | $-301M | |
| Financing Cash Flow | $-957M | $-983M | $-711M | $-1.58B | $-356M | $-487M | $-116M | $-1.10B | $-473M | $-268M | $-159M | · | |
| Net Change in Cash | $-119M | $1.91B | $375M | $-95M | $-333M | $16M | $468M | $-104M | $-112M | $212M | $65M | $233M | |
| Taxes Paid | $490M | $1.20B | $470M | · | · | · | · | · | · | · | · | $275M | |
| Free Cash Flow | $1.33B | $290M | $643M | $974M | $1.41B | $647M | $925M | $688M | $833M | $528M | $447M | $939M | |
| Levered FCF | · | · | $627M | $957M | $1.39B | $633M | $906M | $660M | $820M | $513M | $433M | $927M |
Profitabilitas 8
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.0% | 79.5% | 77.0% | 79.9% | 76.1% | 75.4% | 74.4% | 74.8% | 74.5% | 73.1% | 75.2% | 73.1% | |
| Operating Margin | 20.8% | 25.4% | 25.6% | 32.5% | 32.3% | 20.5% | 26.4% | 20.1% | · | · | · | · | |
| Net Margin | 17.7% | 76.8% | 23.4% | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | 21.0% | 28.5% | 26.6% | 32.8% | 32.5% | 20.9% | 26.8% | 20.4% | 30.1% | 24.9% | 25.0% | 49.2% | |
| EBITDA Margin | 23.4% | 28.2% | 28.0% | 35.1% | 34.9% | 22.9% | 28.4% | 22.2% | 2.4% | 2.4% | 2.6% | 2.9% | |
| ROA | 8.0% | 37.2% | 15.9% | · | · | · | · | · | · | · | · | · | |
| ROE | 10.6% | 50.1% | 22.5% | · | · | · | · | · | · | · | · | · | |
| ROIC | 9.6% | 11.7% | 18.5% | 23.5% | 23.2% | 15.6% | 21.7% | 19.0% | · | · | · | · |
Likuiditas & Solvabilitas 5
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 4.2 | 3.4 | 3.0 | 3.1 | 3.5 | 3.3 | 2.6 | 1.8 | 4.2 | 4.3 | 5.3 | |
| Quick Ratio | 2.7 | 3.0 | 2.0 | 1.8 | 2.0 | 2.1 | 2.3 | 1.6 | 1.3 | 3.1 | 3.2 | 4.0 | |
| Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.4 | 0.3 | 0.2 | 0.3 | |
| LT Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.3 | 0.2 | 0.3 | |
| Interest Coverage | · | · | 87.2 | 91.1 | 91.9 | 56.8 | 55.4 | 25.0 | · | · | · | · |
Efisiensi 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.7 | 0.6 | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | |
| Inventory Turnover | 1.2 | 1.1 | 1.4 | 1.3 | 1.6 | 1.5 | 1.8 | 1.6 | 1.8 | 2.2 | 1.9 | 2.1 | |
| Receivables Turnover | 9.6 | 7.9 | 8.5 | 8.8 | 9.5 | 8.3 | 8.7 | 8.3 | 8.7 | 8.7 | 8.3 | 7.9 |
Tingkat Pertumbuhan 8
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.6% | 8.6% | 12.2% | -14.7% | 19.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.8% | 1.3% | 4.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.7% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -73.7% | 203.0% | -5.7% | 2.5% | 83.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -9.1% | 43.1% | 20.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 7.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -74.3% | 197.7% | -7.8% | 1.2% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -11.0% | 40.6% | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.07B | $5.44B | $5.01B | $4.46B | $5.23B | $4.39B | $4.35B | $3.72B | $3.44B | $2.96B | $2.49B | $2.32B | |
| Net Income TTM | $1.07B | $4.17B | $1.40B | $1.52B | $1.50B | $235M | $235M | $235M | $235M | $235M | $235M | $235M | |
| Market Cap | $49.50B | $43.57B | $45.83B | $45.39B | $80.85B | $56.95B | $16.26B | $10.60B | $7.88B | $6.61B | $5.67B | $2.29B | |
| Enterprise Value | $45.88B | $40.20B | $44.79B | $44.77B | $79.98B | $56.15B | $15.34B | $10.24B | $7.58B | $6.16B | $5.05B | $1.45B | |
| P/E | 46.6 | 10.6 | 33.2 | 30.6 | 54.4 | 70.2 | 47.4 | 45.2 | 13.9 | 12.0 | 11.7 | 5.7 | |
| P/S | 8.2 | 8.0 | 9.1 | 10.2 | 15.5 | 13.0 | 3.7 | 2.8 | 2.3 | 2.2 | 2.3 | 1.0 | |
| P/B | 4.8 | 4.4 | 6.9 | 7.8 | 13.9 | 12.5 | 3.9 | 3.4 | 2.7 | 2.5 | 2.3 | 1.0 | |
| P / Tangible Book | 6.7 | 6.2 | 9.0 | 10.2 | 18.6 | 18.6 | · | · | · | · | · | · | |
| P / Cash Flow | 31.0 | 80.4 | 51.2 | 37.3 | 46.7 | 54.0 | 13.8 | 11.4 | 7.9 | 9.4 | 10.3 | 2.2 | |
| P / FCF | 37.1 | 150.3 | 71.3 | 46.6 | 57.5 | 88.0 | 17.6 | 15.4 | 9.5 | 12.5 | 12.7 | 2.4 | |
| EV / EBITDA | 32.3 | 26.2 | 26.7 | 23.7 | 43.8 | 55.9 | 12.4 | 12.4 | 92.5 | 86.5 | 76.7 | 21.1 | |
| EV / FCF | 34.4 | 138.7 | 69.7 | 46.0 | 56.9 | 86.7 | 16.6 | 14.9 | 9.1 | 11.7 | 11.3 | 1.5 | |
| EV / Revenue | 7.6 | 7.4 | 8.9 | 10.0 | 15.3 | 12.8 | 3.5 | 2.8 | 2.2 | 2.1 | 2.0 | 0.6 | |
| Earnings Yield | 2.1% | 9.4% | 3.0% | 3.3% | 1.8% | 1.4% | 2.1% | 2.2% | 7.2% | 8.4% | 8.6% | 17.6% |
Laporan Laba Rugi 16
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.74B | $1.65B | $1.57B | $1.55B | $1.53B | $1.41B | $1.39B | $1.35B | $1.37B | $1.33B | $1.01B | $1.24B | $1.28B | $1.22B | $430M | $1.32B | |
| Cost of Revenue | $392M | $363M | $343M | $345M | $344M | $302M | $292M | $263M | $276M | $287M | $141M | $251M | $257M | $330M | $-99M | $254M | |
| Gross Profit | $1.35B | $1.29B | $1.23B | $1.21B | $1.19B | $1.11B | $1.09B | $1.09B | $1.09B | $1.04B | $870M | $993M | $1.03B | $992M | $529M | $1.07B | |
| R&D Expense | $279M | $263M | $268M | $281M | $276M | $255M | $271M | $253M | $272M | $257M | $215M | $243M | $244M | $261M | $131M | $234M | |
| SG&A Expense | $561M | $522M | $603M | $515M | $502M | $466M | $492M | $421M | $448M | $428M | $354M | $382M | $410M | $436M | $201M | $377M | |
| Operating Income | $513M | $478M | $151M | $307M | $411M | $395M | $313M | $351M | $366M | $349M | $291M | $366M | $264M | $388M | $198M | $402M | |
| Interest Income | $30M | $34M | · | · | $37M | $36M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $17M | $72M | $3M | $3M | $-1M | $3M | $33M | $28M | $2M | $6M | $3M | $7M | $2M | $2M | $6M | $-2M | |
| Pretax Income | $520M | $459M | $90M | $348M | $400M | $434M | $390M | $403M | $384M | $371M | $311M | $388M | $275M | $399M | $211M | $407M | |
| Income Tax | $278M | $78M | $26M | $56M | $64M | $70M | $45M | $41M | $20M | $46M | $21M | $53M | $21M | $58M | $11M | $64M | |
| Net Income | $242M | $381M | $91M | $291M | $333M | $358M | $386M | $3.07B | $366M | $352M | $370M | $385M | $307M | $340M | $398M | $344M | |
| EPS (Basic) | $0.42 | $0.66 | $0.16 | $0.50 | $0.57 | $0.61 | $0.65 | $5.14 | $0.61 | $0.58 | $0.61 | $0.63 | $0.51 | $0.56 | $0.66 | $0.55 | |
| EPS (Diluted) | $0.42 | $0.66 | $0.16 | $0.50 | $0.56 | $0.61 | $0.65 | $5.13 | $0.61 | $0.58 | $0.61 | $0.63 | $0.50 | $0.56 | $0.65 | $0.55 | |
| Shares (Basic) | 576,400,000 | 579,200,000 | -1,173,800,000 | 584,700,000 | 587,000,000 | 586,900,000 | -1,203,200,000 | 597,200,000 | 602,100,000 | 601,600,000 | -1,214,700,000 | 607,000,000 | 606,900,000 | 607,500,000 | -1,243,800,000 | 619,800,000 | |
| Shares (Diluted) | 577,600,000 | 580,700,000 | -1,175,600,000 | 585,700,000 | 587,900,000 | 587,800,000 | -1,207,200,000 | 598,100,000 | 604,300,000 | 604,100,000 | -1,221,300,000 | 609,500,000 | 610,300,000 | 610,900,000 | -1,256,400,000 | 624,500,000 | |
| EBITDA | $513M | $518M | · | $307M | $411M | $431M | · | $351M | $369M | $426M | · | $418M | $327M | $424M | · | $402M |
Neraca 27
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.91B | $2.45B | $2.94B | $2.69B | $3.27B | $3.14B | $3.05B | $3.68B | $1.64B | $1.22B | · | $1.41B | $1.04B | $872M | · | $1.25B | |
| Short-term Investments | $1.35B | $1.23B | $1.29B | $1.16B | $789M | $758M | $931M | $770M | $345M | $473M | · | $454M | $467M | $382M | · | $491M | |
| Receivables | $770M | $776M | $660M | $693M | $697M | $669M | $609M | $716M | $778M | $818M | · | $740M | $754M | $718M | · | $618M | |
| Inventory | $1.13B | $1.12B | $1.13B | $1.14B | $1.14B | $1.11B | $1.09B | $1.10B | $1.02B | $1.21B | · | $1.03B | $980M | $914M | · | $758M | |
| Prepaid Expense | $119M | $136M | $135M | $125M | $110M | $111M | $121M | $115M | $110M | $138M | · | $133M | $123M | $119M | · | $88M | |
| Other Current Assets | $360M | $330M | $339M | $323M | $314M | $304M | $348M | $231M | $252M | $251M | · | $236M | $217M | $190M | · | $268M | |
| Current Assets | $6.82B | $6.23B | $6.74B | $6.36B | $6.58B | $6.21B | $6.29B | $6.73B | $4.52B | $4.17B | · | $4.07B | $3.65B | $3.26B | · | $3.51B | |
| PP&E (Net) | $1.84B | $1.82B | $1.81B | $1.74B | $1.73B | $1.70B | $1.69B | $1.68B | $1.64B | $1.77B | · | $1.68B | $1.66B | $1.65B | · | $1.57B | |
| PP&E (Gross) | · | · | $2.66B | · | · | · | $2.48B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $850M | · | · | · | $794M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $1.95B | $1.82B | $1.77B | $1.77B | $1.78B | $1.78B | $1.78B | $1.61B | $1.15B | $1.25B | $1.15B | $1.30B | $1.30B | $1.31B | $1.06B | $1.16B | |
| Intangibles | $1.38B | $1.23B | $1.13B | $1.13B | $1.17B | $1.17B | $1.18B | $956M | $417M | $447M | · | $430M | $431M | $447M | · | $266M | |
| Other Non-current Assets | $616M | $739M | $730M | $785M | $743M | $743M | $722M | $684M | $790M | $768M | · | $447M | $412M | $294M | · | $316M | |
| Total Assets | $13.87B | $13.32B | $13.70B | $13.27B | $13.49B | $13.02B | $13.06B | $12.97B | $10.10B | $9.74B | · | $9.37B | $9.00B | $8.65B | · | $8.64B | |
| Accounts Payable | $210M | $181M | $228M | $165M | $162M | $172M | $197M | $173M | $186M | $212M | · | $191M | $193M | $181M | · | $155M | |
| Current Liabilities | $1.51B | $1.41B | $1.81B | $1.59B | $1.40B | $1.39B | $1.51B | $1.94B | $1.22B | $1.11B | · | $1.24B | $1.16B | $1.08B | · | $918M | |
| Capital Leases | $82M | $80M | $83M | $75M | $79M | $78M | $79M | $85M | $74M | $77M | · | $70M | $64M | $66M | · | $67M | |
| Other Non-current Liabilities | $382M | $351M | $362M | $363M | $379M | $358M | $373M | $323M | $257M | $266M | · | $240M | $243M | $260M | · | $221M | |
| Total Liabilities | $3.14B | $2.99B | $3.36B | $3.07B | $2.88B | $2.83B | $2.99B | $3.36B | $2.59B | $2.55B | · | $2.64B | $2.56B | $2.59B | · | $2.42B | |
| Total Debt | $599M | $598M | · | $598M | $598M | $598M | · | $598M | $597M | $597M | · | $597M | $597M | $596M | · | $596M | |
| Common Stock | $662M | $660M | $659M | $658M | $658M | $656M | $655M | $654M | $654M | $652M | · | $650M | $649M | $647M | · | $646M | |
| Retained Earnings | $14.86B | $14.62B | $14.24B | $14.15B | $13.86B | $13.53B | $13.17B | $12.78B | $9.71B | $9.34B | · | $8.62B | $8.24B | $7.93B | · | $7.19B | |
| Treasury Stock | $7.67B | $7.51B | $7.09B | $7.05B | $6.46B | $6.45B | $6.19B | $6.09B | $5.18B | $5.02B | · | $4.58B | $4.40B | $4.39B | · | $3.28B | |
| AOCI | $-215M | $-221M | $-238M | $-250M | $-264M | $-254M | $-244M | $-252M | $-220M | $-233M | · | $-250M | $-256M | $-255M | · | $-256M | |
| Stockholders' Equity | $10.62B | $10.33B | $10.34B | $10.21B | $10.55B | $10.13B | $10.00B | $9.55B | $7.44B | $7.12B | · | $6.66B | $6.38B | $5.98B | · | $6.22B | |
| Liabilities + Equity | $13.87B | $13.32B | $13.70B | $13.27B | $13.49B | $13.02B | $13.06B | $12.97B | $10.10B | $9.74B | · | $9.37B | $9.00B | $8.65B | · | $8.64B | |
| Shares Outstanding | 576,600,000 | 577,000,000 | 580,700,000 | 580,700,000 | 587,900,000 | 586,200,000 | 588,600,000 | 589,800,000 | 602,300,000 | 602,400,000 | 650,500,000 | 606,500,000 | 607,900,000 | 606,000,000 | 646,300,000 | 619,400,000 |
Arus Kas 13
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $43M | $41M | $43M | $39M | $38M | $37M | $43M | $34M | $40M | $38M | $37M | $37M | $36M | $35M | $35M | $35M | |
| Stock-based Comp | $42M | $45M | $39M | $41M | $38M | $40M | $32M | $42M | $44M | $45M | $30M | $33M | $37M | $39M | $28M | $30M | |
| Restructuring | · | · | $5M | $100.0K | · | · | $0 | $33M | · | · | · | $0 | · | · | · | · | |
| Other Non-cash | · | $-423M | · | · | · | $-154M | · | · | · | $-488M | · | · | · | · | · | · | |
| Operating Cash Flow | $652M | $44M | $451M | $574M | $290M | $280M | $-128M | $352M | $372M | $-54M | $137M | $412M | $34M | $314M | $283M | $310M | |
| CapEx | $67M | $65M | $97M | $58M | $49M | $56M | $50M | $52M | $85M | $65M | $88M | $55M | $48M | $62M | $69M | $60M | |
| Investing Cash Flow | $-193M | $-93M | $-198M | $-428M | $-172M | $85M | $-577M | $2.70B | $125M | $63M | $14M | $89M | $70M | $500.0K | $95M | $-202M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stock Repurchased | $153M | $422M | $41M | $589M | $6M | $259M | $100M | $901M | $158M | $200.0K | $448M | $174M | $8M | $249M | $866M | $100M | |
| Net Stock Activity | · | $-422M | · | · | · | $-259M | · | · | · | $-200.0K | · | · | · | $-249M | · | · | |
| Financing Cash Flow | $-300.0K | $-451M | $-11M | $-740M | $53M | $-258M | $29M | $-977M | $-97M | $62M | $-413M | $-143M | $52M | $-207M | $-838M | $-70M | |
| Net Change in Cash | $462M | $-492M | $245M | $-595M | $141M | $90M | $-625M | $2.03B | $429M | $81M | $-266M | $366M | $171M | $104M | $-479M | $49M | |
| Free Cash Flow | · | $-21M | · | · | · | $224M | · | · | · | $-119M | · | · | · | $253M | · | · |
Profitabilitas 8
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 77.5% | 78.0% | · | 77.8% | 77.5% | 78.6% | · | 80.6% | 79.4% | 75.9% | · | 76.3% | 77.6% | 77.4% | · | 80.8% | |
| Operating Margin | 29.5% | 29.0% | · | 19.8% | 26.8% | 28.0% | · | 25.9% | 26.6% | 24.2% | · | 28.2% | 21.4% | 26.6% | · | 30.5% | |
| Net Margin | 13.9% | 23.1% | · | 18.7% | 21.8% | 25.3% | · | 226.7% | 26.4% | 22.0% | · | 26.0% | 20.1% | · | · | · | |
| Pretax Margin | 29.9% | 27.8% | · | 22.4% | 26.1% | 30.7% | · | 29.7% | 27.9% | 25.6% | · | 29.7% | 22.1% | 27.3% | · | 30.9% | |
| EBITDA Margin | 29.5% | 31.4% | · | 19.8% | 26.8% | 30.5% | · | 25.9% | 26.6% | 26.7% | · | 28.2% | 21.4% | 29.0% | · | 30.5% | |
| ROA | 1.8% | 2.9% | · | 2.2% | 2.8% | 3.1% | · | 27.5% | 3.8% | 3.8% | · | 4.3% | 3.5% | · | · | · | |
| ROE | 2.3% | 3.7% | · | 2.9% | 3.7% | 4.2% | · | 37.9% | 5.3% | 5.4% | · | 6.0% | 5.0% | · | · | · | |
| ROIC | 2.1% | 3.6% | · | 2.4% | 3.1% | 3.1% | · | 3.1% | 4.3% | 4.3% | · | 5.0% | 4.2% | 5.1% | · | 5.0% |
Likuiditas & Solvabilitas 4
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 4.4 | · | 4.0 | 4.7 | 4.5 | · | 3.5 | 3.7 | 3.8 | · | 3.3 | 3.2 | 3.0 | · | 3.8 | |
| Quick Ratio | 3.3 | 3.2 | · | 2.9 | 3.4 | 3.3 | · | 2.7 | 2.3 | 2.3 | · | 2.1 | 2.0 | 1.8 | · | 2.6 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
Efisiensi 3
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | |
| Receivables Turnover | 2.4 | 2.3 | · | 2.2 | 2.1 | 1.9 | · | 1.9 | 1.8 | 2.1 | · | 2.2 | 2.2 | 2.2 | · | 2.2 |
Valuasi (TTM) 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.47B | $6.15B | · | $5.88B | $5.69B | $5.52B | · | $5.32B | $5.21B | $5.12B | · | $5.06B | $5.19B | $5.26B | · | $5.34B | |
| Net Income TTM | $1.25B | $1.36B | · | $1.37B | $4.15B | $4.18B | · | $4.16B | $1.47B | $1.41B | · | $1.38B | $1.40B | · | · | · | |
| Market Cap | $52.16B | $46.21B | · | $45.16B | $45.98B | $42.49B | · | $38.92B | $55.63B | $57.57B | · | $42.02B | $57.34B | $50.13B | · | $51.18B | |
| Enterprise Value | $48.51B | $43.13B | · | $41.92B | $42.52B | $39.19B | · | $35.07B | $54.24B | $56.46B | · | $40.75B | $56.43B | $49.48B | · | $50.04B | |
| P/E | 42.3 | 34.4 | · | 33.5 | 11.3 | 10.4 | · | 9.5 | 38.0 | 41.2 | · | 30.9 | 41.7 | 35.2 | · | 35.5 | |
| P/S | 8.1 | 7.5 | · | 7.7 | 8.1 | 7.7 | · | 7.3 | 10.7 | 11.2 | · | 8.3 | 11.0 | 9.5 | · | 9.6 | |
| P/B | 4.9 | 4.5 | · | 4.4 | 4.4 | 4.2 | · | 4.1 | 7.5 | 8.1 | · | 6.3 | 9.0 | 8.4 | · | 8.2 | |
| P / Tangible Book | 7.2 | 6.3 | · | 6.2 | 6.1 | 5.9 | · | 5.6 | 9.5 | 10.6 | · | 8.5 | 12.3 | 11.9 | · | 10.7 | |
| P / Cash Flow | · | 1054.9 | · | · | · | 151.5 | · | · | · | -1076.0 | · | · | · | 159.6 | · | · | |
| P / FCF | · | -2189.9 | · | · | · | 189.3 | · | · | · | -484.6 | · | · | · | 198.5 | · | · | |
| EV / EBITDA | 94.5 | 83.2 | · | 136.5 | 103.4 | 90.8 | · | 100.0 | 147.0 | 132.5 | · | 97.4 | 172.5 | 116.8 | · | 124.4 | |
| EV / FCF | · | -2044.2 | · | · | · | 174.6 | · | · | · | -475.3 | · | · | · | 195.9 | · | · | |
| EV / Revenue | 7.5 | 7.0 | · | 7.1 | 7.5 | 7.1 | · | 6.6 | 10.4 | 11.0 | · | 8.0 | 10.9 | 9.4 | · | 9.4 | |
| Earnings Yield | 2.4% | 2.9% | · | 3.0% | 8.9% | 9.7% | · | 10.5% | 2.6% | 2.4% | · | 3.2% | 2.4% | 2.8% | · | 2.8% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $6.07B | $5.44B | $5.01B | $4.46B | $5.23B |
| Margin Kotor % | 78.0% | 79.5% | 77.0% | 79.9% | 76.1% |
| Margin Operasi % | 20.8% | 25.4% | 25.6% | 32.5% | 32.3% |
| Laba Bersih | $1.07B | $4.17B | $1.40B | $1.52B | $1.50B |
| EPS Dilusian | $1.83 | $6.97 | $2.30 | $2.44 | $2.38 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Rasio Lancar | 3.7 | 4.2 | 3.4 | 3.0 | 3.1 |
| Rasio Cepat | 2.7 | 3.0 | 2.0 | 1.8 | 2.0 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $1.33B | $290M | $643M | $974M | $1.41B |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 1.449 pengaju · $30.3B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 152 (+6 vs Kuartal sebelumnya) | 97 (-10 vs Kuartal sebelumnya) | 459 (+11 vs Kuartal sebelumnya) | 452 (+4 vs Kuartal sebelumnya) | +26.4M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3.402.739.018 | 37.615.952 | 11,24% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.389.175.425 | 26.411.402 | 7,89% | Saham |
| STATE STREET CORP | $2.381.082.692 | 26.321.940 | 7,87% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $1.430.999.585 | 15.819.142 | 4,73% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $1.219.437.867 | 13.541.730 | 4,03% | Saham |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $1.135.640.991 | 12.554.068 | 3,75% | Saham |
| Ninety One UK Ltd | $1.116.050.276 | 12.337.502 | 3,69% | Saham |
| Aristotle Capital Management, LLC | $783.906.442 | 8.665.712 | 2,59% | Saham |
| NORGES BANK | $757.492.410 | 8.373.783 | 2,50% | Saham |
| ALLIANCEBERNSTEIN L.P. | $693.526.113 | 8.660.416 | 2,29% | Saham |
| FMR LLC | $607.177.379 | 6.712.109 | 2,01% | Saham |
| Artisan Partners Limited Partnership | $599.361.052 | 6.625.703 | 1,98% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $513.572.538 | 5.677.344 | 1,70% | Saham |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | $434.208.000 | 4.800.000 | 1,43% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $334.052.859 | 3.692.824 | 1,10% | Saham |
| MILLENNIUM MANAGEMENT LLC | $324.280.556 | 3.584.795 | 1,07% | Saham |
| CITADEL ADVISORS LLC | $308.338.066 | 3.408.557 | 1,02% | Saham |
| PRIMECAP MANAGEMENT CO/CA/ | $308.314.004 | 3.408.291 | 1,02% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $298.865.427 | 3.303.843 | 0,99% | Saham |
| BROWN ADVISORY INC | $295.062.880 | 3.261.805 | 0,97% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $292.399.738 | 3.232.365 | 0,97% | Saham |
| Holocene Advisors, LP | $283.979.721 | 3.139.285 | 0,94% | Saham |
| NEUBERGER BERMAN GROUP LLC | $255.069.412 | 2.818.763 | 0,84% | Saham |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $250.776.107 | 2.772.232 | 0,83% | Saham |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $238.277.000 | 2.634.054 | 0,79% | Saham |
| Mirova US LLC | $229.802.865 | 2.540.381 | 0,76% | Saham |
| BANK OF AMERICA CORP /DE/ | $170.884.489 | 1.889.061 | 0,56% | Saham |
| BlackRock, Inc. | $168.018.323 | 1.857.377 | 0,55% | Saham |
| Assenagon Asset Management S.A. | $163.997.286 | 1.812.926 | 0,54% | Saham |
| Point72 Asset Management, L.P. | $160.486.895 | 1.774.120 | 0,53% | Saham |
| RAYMOND JAMES FINANCIAL INC | $152.806.000 | 1.689.211 | 0,50% | Saham |
| Swiss National Bank | $147.097.006 | 1.626.100 | 0,49% | Saham |
| Woodline Partners LP | $141.123.209 | 1.560.062 | 0,47% | Saham |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $140.351.128 | 1.551.434 | 0,46% | Saham |
| TWO SIGMA INVESTMENTS, LP | $137.670.984 | 1.521.899 | 0,45% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $131.472.173 | 1.453.357 | 0,43% | Saham |
| Mitsubishi UFJ Asset Management Co., Ltd. | $126.120.870 | 1.394.217 | 0,42% | Saham |
| Legal & General Group Plc | $121.108.845 | 1.338.811 | 0,40% | Saham |
| ROYAL BANK OF CANADA | $119.193.000 | 1.317.637 | 0,39% | Saham |
| Sumitomo Mitsui Trust Group, Inc. | $113.885.341 | 1.258.958 | 0,38% | Saham |
| Quantinno Capital Management LP | $113.292.795 | 1.252.407 | 0,37% | Saham |
| Vanguard Global Advisers, LLC | $112.247.472 | 1.240.852 | 0,37% | Saham |
| Liontrust Investment Partners LLP | $110.033.644 | 1.216.379 | 0,36% | Saham |
| VANGUARD GROUP INC | $107.656.172 | 1.262.829 | 0,36% | Saham |
| SEB Asset Management AB | $106.981.085 | 1.182.636 | 0,35% | Saham |
| VANGUARD ASSET MANAGEMENT, Ltd | $100.522.409 | 1.111.236 | 0,33% | Saham |
| Polar Capital Holdings Plc | $99.945.636 | 1.104.860 | 0,33% | Saham |
| RHUMBLINE ADVISERS | $99.213.696 | 1.096.770 | 0,33% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $92.822.996 | 1.026.122 | 0,31% | Saham |
| PARNASSUS INVESTMENTS, LLC | $91.873.890 | 1.015.630 | 0,30% | Saham |
| Bank of New York Mellon Corp | $91.654.072 | 1.013.200 | 0,30% | Saham |
| National Pension Service | $90.349.187 | 998.775 | 0,30% | Saham |
| California Public Employees Retirement System | $89.091.250 | 984.869 | 0,29% | Saham |
| Caisse de depot et placement du Quebec | $87.523.397 | 967.537 | 0,29% | Saham |
| ABN AMRO Bank N.V. | $83.573.385 | 924.314 | 0,28% | Saham |
| GOLDMAN SACHS GROUP INC | $82.454.109 | 911.498 | 0,27% | Saham |
| Empower Advisory Group, LLC | $80.384.543 | 888.620 | 0,27% | Saham |
| Meridiem Capital Partners LP | $77.697.994 | 858.921 | 0,26% | Saham |
| Man Group plc | $76.372.212 | 844.265 | 0,25% | Saham |
| ORBIMED ADVISORS LLC | $75.525.054 | 834.900 | 0,25% | Saham |
| Alyeska Investment Group, L.P. | $73.531.316 | 812.860 | 0,24% | Saham |
| Nantahala Capital Management, LLC | $72.368.000 | 800.000 | 0,24% | Opsi jual |
| CANADA PENSION PLAN INVESTMENT BOARD | $72.254.020 | 798.740 | 0,24% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $69.805.736 | 871.700 | 0,23% | Saham |
| ENVESTNET ASSET MANAGEMENT INC | $66.940.606 | 740.002 | 0,22% | Saham |
| Bellevue Group AG | $66.871.108 | 739.234 | 0,22% | Saham |
| Birch Hill Investment Advisors LLC | $66.522.203 | 735.377 | 0,22% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $64.772.074 | 716.030 | 0,21% | Saham |
| TD Asset Management Inc | $61.560.472 | 680.527 | 0,20% | Saham |
| PRINCIPAL FINANCIAL GROUP INC | $61.491.904 | 679.769 | 0,20% | Saham |
| UBS Group AG | $60.908.889 | 673.324 | 0,20% | Saham |
| Candriam S.C.A. | $59.988.129 | 663.784 | 0,20% | Saham |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $57.604.363 | 675.711 | 0,19% | Saham |
| Integral Health Asset Management, LLC | $56.537.500 | 625.000 | 0,19% | Saham |
| Ninety One North America, Inc. | $55.768.413 | 616.498 | 0,18% | Saham |
| Robeco Institutional Asset Management B.V. | $55.270.246 | 610.991 | 0,18% | Saham |
| Seilern Investment Management Ltd | $54.296.896 | 600.231 | 0,18% | Saham |
| Nan Shan Life Insurance Co., Ltd. | $49.953.912 | 552.221 | 0,17% | Saham |
| PFA Pension, Forsikringsaktieselskab | $49.175.025 | 543.611 | 0,16% | Saham |
| BARCLAYS PLC | $49.135.520 | 543.174 | 0,16% | Saham |
| Triodos Investment Management BV | $44.629.165 | 493.358 | 0,15% | Saham |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $44.266.149 | 489.345 | 0,15% | Saham |
| Mitsubishi UFJ Trust & Banking Corp | $43.182.890 | 477.370 | 0,14% | Saham |
| APG Asset Management N.V. | $42.840.046 | 541.444 | 0,14% | Saham |
| United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund | $42.480.287 | 469.603 | 0,14% | Saham |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $42.097.461 | 465.371 | 0,14% | Saham |
| AVIVA PLC | $41.577.497 | 459.623 | 0,14% | Saham |
| Balyasny Asset Management L.P. | $41.248.584 | 455.987 | 0,14% | Saham |
| Korea Investment CORP | $40.486.097 | 447.558 | 0,13% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $39.585.296 | 437.600 | 0,13% | Opsi beli |
| NORDEA INVESTMENT MANAGEMENT AB | $37.761.927 | 418.322 | 0,12% | Saham |
| STOREBRAND ASSET MANAGEMENT AS | $37.671.343 | 416.442 | 0,12% | Saham |
| Qube Research & Technologies Ltd | $37.490.061 | 414.438 | 0,12% | Saham |
| OFI INVEST ASSET MANAGEMENT | $36.480.086 | 458.427 | 0,12% | Saham |
| Fisher Funds Management LTD | $35.971.057 | 397.646 | 0,12% | Saham |
| LPL Financial LLC | $34.985.891 | 386.755 | 0,12% | Saham |
| ABN AMRO INVESTMENT SOLUTIONS | $33.668.217 | 372.189 | 0,11% | Saham |
| AMERIPRISE FINANCIAL INC | $32.517.021 | 359.463 | 0,11% | Saham |
| BLAIR WILLIAM & CO/IL | $32.206.687 | 356.032 | 0,11% | Saham |
| Champlain Investment Partners, LLC | $31.357.054 | 346.640 | 0,10% | Saham |
Orang dalam perusahaan 48 orang dalam · 18 pejabat · 8 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Bernard J Zovighian | CEO | 27 Juli 2026 S | 8.916 | 0 | 8 | $-6.996.971 |
| Theodora Mistras | CVP, Chief Financial Officer | 9 Juli 2026 A | 99.920 | 0 | 0 | $0 |
| Thomas M Abate | CVP, CFO | 14 Mei 2013 A | 43.047 | 0 | 0 | $0 |
| Wayne Markowitz | CVP, JAPAC | 30 Juli 2026 S | 21.534 | 0 | 4 | $-928.942 |
| Annette Bruls | CVP, EMEACLA | 11 Juli 2026 F | 20.628 | 0 | 0 | $0 |
| Andrew M. Dahl | SVP, Corporate Controller | 29 Mei 2026 S | 15.334 | 0 | 1 | $-48.893 |
| Carlyn D Solomon | CVP, Critical Care & Vascular | 28 Okt. 2014 M | 31.154 | 0 | 0 | $0 |
| Christine Z Mccauley | CVP, Human Resources | 13 Mei 2013 F | 4.035 | 0 | 0 | $0 |
| Paul C Redmond | CVP, Global Operations | 13 Mei 2013 S | 12.534 | 0 | 0 | $0 |
| Bruce P Garren | CVP, Public Affairs/Special Co | 13 Mei 2013 F | 56.071 | 0 | 0 | $0 |
| John H Kehl JR | CVP, Strategy & Corp Dev | 7 Mei 2013 F | 101.767 | 0 | 0 | $0 |
| Robert C Reindl | CVP, H.R. and Communications | 27 Juli 2012 M | 1.124 | 0 | 0 | $0 |
| Aimee S Weisner | CVP, General Counsel | 9 Mei 2012 A | 1.675 | 0 | 0 | $0 |
| Corinne H Nevinny | CVP & Pres., Global Ops | 13 Mei 2010 A | 16.687 | 0 | 0 | $0 |
| Anita Bessler | CVP | 31 Agu 2007 S | 29.410 | 0 | 0 | $0 |
| John Alexander Martin | CVP, North America | 10 Mei 2007 A | 15.300 | 0 | 0 | $0 |
| Stuart L Foster | CVP, Critical Care / Vascular | 10 Mei 2007 A | 24.604 | 0 | 0 | $0 |
| Randel William Woodgrift | Corp VP, Manufacturing Ops | 4 Agu 2005 M | 3.349 | 0 | 0 | $0 |
| John T Cardis | Direktur | 10 Agu 2016 S | 91.458 | 0 | 0 | $0 |
| Barbara J Mcneil | Direktur | 4 Feb. 2016 S | 46.454 | 0 | 0 | $0 |
| Robert Alexander Ingram | Direktur | 15 Mei 2015 A | 32.367 | 0 | 0 | $0 |
| Michael R Bowlin | Direktur | 14 Nov. 2014 M | 81.751 | 0 | 0 | $0 |
| David E I Pyott | Direktur | 9 Mei 2014 A | 53.582 | 0 | 0 | $0 |
| NEAL PHILIP M | Direktur | 12 Agu 2008 M | 27.333 | 0 | 0 | $0 |
| Vernon R Loucks JR | Direktur | 9 Mei 2008 A | 24.133 | 0 | 0 | $0 |
| Daniel J. Lippis | — | 11 Agu 2026 M | 40.034 | 0 | 12 | $-817.452 |
| Donald E Bobo JR | — | 27 Mei 2026 S | 98.611 | 0 | 12 | $-11.153.294 |
| Daveen Chopra | — | 22 Mei 2026 S | 44.324 | 0 | 3 | $-500.535 |
| Scott B. Ullem | — | 11 Mei 2026 M | 46.740 | 0 | 7 | $-3.875.008 |
| Leslie C. Davis | — | 8 Mei 2026 A | 9.834 | 0 | 0 | $0 |
| Ramona Sequeira | — | 8 Mei 2026 A | 6.779 | 0 | 0 | $0 |
| David T Feinberg | — | 8 Mei 2026 A | 9.087 | 0 | 0 | $0 |
| Kieran Gallahue | — | 8 Mei 2026 A | 4.315 | 0 | 0 | $0 |
| Nicholas J Valeriani | — | 8 Mei 2026 A | 84.423 | 0 | 0 | $0 |
| Heisz Leslie Stone | — | 8 Mei 2026 A | 34.199 | 0 | 1 | $-218.117 |
| Steven R Loranger | — | 8 Mei 2026 A | 8.997 | 0 | 0 | $0 |
| Paul A Laviolette | — | 8 Mei 2026 A | 17.552 | 0 | 0 | $0 |
| Larry L Wood | — | 18 Agu 2025 M | 206.900 | 0 | 0 | $0 |
| Catherine M. Szyman | — | 3 Sep. 2024 F | 81.287 | 0 | 0 | $0 |
| Jean-Luc M Lemercier | — | 7 Juli 2024 F | 184.686 | 0 | 0 | $0 |
| Robert W.A. Sellers | — | 11 Mei 2024 F | 17.081 | 0 | 0 | $0 |
| Michael A Mussallem | — | 2 Mei 2024 M | 4.486 | 0 | 0 | $0 |
| Martha H. Marsh | — | 12 Mei 2023 A | 31.880 | 0 | 0 | $0 |
| Huimin Wang | — | 8 Juli 2022 M | 99.381 | 0 | 0 | $0 |
| William J Link PHD | — | 8 Mei 2020 A | 11.349 | 0 | 0 | $0 |
| Wesley W Von Schack | — | 1 Agu 2019 S | 8.000 | 0 | 0 | $0 |
| Patrick B Verguet | — | 31 Mei 2017 M | 129.137 | 0 | 0 | $0 |
| Randall J Nelson | — | 30 Sep. 2003 A | — | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 1 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Orang pelapor yang tidak diungkapkan | 5 April 2001 | — | Pengajuan awal | Kampanye dewan | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 180 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IHI · iShares Trust | 4,29% | 1.607.851 SH | 8 Agu 2026 | Harian |
| GDOC · Goldman Sachs ETF Trust | 2,98% | 6.939 NS | 31 Mei 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 2,11% | 10.000 NS | 31 Mei 2026 | N-PORT |
| ANEW · ProShares Trust | 2,02% | 1.801 NS | 31 Mei 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,83% | 2.435 NS | 30 April 2026 | N-PORT |
| PJBF · PGIM ETF Trust | 1,75% | 2.374 NS | 29 Mei 2026 | N-PORT |
| HRTS · Tema ETF Trust | 1,75% | 10.488 NS | 31 Mei 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,58% | 137.940 SH | 8 Agu 2026 | Harian |
| VOT · VANGUARD INDEX FUNDS | 1,14% | 4.411.246 SH | 8 Agu 2026 | Harian |
| ALTL · Pacer Funds Trust | 0,94% | 10.780 NS | 30 April 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 0,93% | 4.325 NS | 30 April 2026 | N-PORT |
| SDG · iShares Trust | 0,90% | 17.447 SH | 8 Agu 2026 | Harian |
| FFND · Northern Lights Fund Trust II | 0,88% | 10.459 NS | 31 Mei 2026 | N-PORT |
| IYH · iShares Trust | 0,83% | 341.366 SH | 8 Agu 2026 | Harian |
| BKDV · BNY Mellon ETF Trust II | 0,81% | 134.666 NS | 30 April 2026 | N-PORT |
| NULV · Nushares ETF Trust | 0,79% | 197.378 NS | 30 April 2026 | N-PORT |
| JOET · Virtus ETF Trust II | 0,79% | 22.410 NS | 30 April 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,78% | 267.514 NS | 30 April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,77% | 1.733.147 SH | 8 Agu 2026 | Harian |
| NULC · Nushares ETF Trust | 0,75% | 5.090 NS | 30 April 2026 | N-PORT |
| RXL · ProShares Trust | 0,73% | 6.052 NS | 31 Mei 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,70% | 11.571 NS | 30 April 2026 | N-PORT |
| IMCG · iShares Trust | 0,66% | 301.692 SH | 8 Agu 2026 | Harian |
| IXJ · iShares Trust | 0,65% | 302.050 SH | 8 Agu 2026 | Harian |
| TEC · Harbor ETF Trust | 0,61% | 491 NS | 30 April 2026 | N-PORT |
| FWD · AB Active ETFs, Inc. | 0,56% | 187.544 NS | 31 Mei 2026 | N-PORT |
| HUSV · First Trust Exchange-Traded Fund III | 0,56% | 4.857 NS | 30 April 2026 | N-PORT |
| BRNY · EA Series Trust | 0,54% | 35.555 NS | 30 April 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,53% | 24.654 NS | 31 Mei 2026 | N-PORT |
| SUSA · iShares Trust | 0,51% | 237.552 SH | 8 Agu 2026 | Harian |
| VO · VANGUARD INDEX FUNDS | 0,50% | 12.477.902 SH | 8 Agu 2026 | Harian |
| IWS · iShares Trust | 0,49% | 860.071 SH | 8 Agu 2026 | Harian |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,42% | 44.305 NS | 30 April 2026 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,40% | 193.493 NS | 30 April 2026 | N-PORT |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 0,37% | 3.768 NS | 30 April 2026 | N-PORT |
| IWR · iShares Trust | 0,36% | 2.320.860 SH | 8 Agu 2026 | Harian |
| IMCB · iShares Trust | 0,34% | 63.843 SH | 8 Agu 2026 | Harian |
| JGLO · J.P. Morgan Exchange-Traded Fund Tr… | 0,34% | 286.558 NS | 30 April 2026 | N-PORT |
| EVUS · iShares Trust | 0,31% | 12.935 SH | 8 Agu 2026 | Harian |
| NBCR · Neuberger Berman ETF Trust | 0,30% | 30.404 NS | 31 Mei 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,29% | 156.342 SH | 8 Agu 2026 | Harian |
| XOEF · iShares Trust | 0,28% | 720 SH | 8 Agu 2026 | Harian |
| ESUM · Strategy Shares | 0,27% | 5.033 NS | 30 April 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,27% | 189.108 NS | 30 April 2026 | N-PORT |
| WINN · Harbor ETF Trust | 0,24% | 31.226 NS | 30 April 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0,24% | 7.428 NS | 29 Mei 2026 | N-PORT |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 887 NS | 30 April 2026 | N-PORT |
| FFLG · FIDELITY COVINGTON TRUST | 0,22% | 15.544 NS | 30 April 2026 | N-PORT |
| CAPE · DoubleLine ETF Trust | 0,22% | 7.122 NS | 31 Maret 2026 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0,21% | 42.168 NS | 31 Mei 2026 | N-PORT |